Platform Technology
Microcrystal Transdermal
Delivery Platform
A dissolvable microneedle architecture that carries pharmaceutical-grade microcrystals through the skin barrier — without needles, without GI involvement, without compromise.
Why it matters
A different class of delivery
Conventional oral supplementation is limited by absorption variability, GI tolerability, and patient adherence. The BioMed Labs platform addresses each of these constraints at the engineering level.
Platform architecture
Six engineering pillars
Microcrystal Matrix Architecture
Each patch contains thousands of precisely engineered microcrystals loaded with active compound. The matrix geometry controls surface area exposure and governs the rate at which compound becomes available at the skin interface.
Dissolvable Microneedle Substrate
The microneedle substrate is fabricated from pharmaceutical-grade dissolvable polymers. On contact with skin moisture, the needle tips soften and release their payload into the upper dermal layers without penetrating the dermis.
Formulation Precision
Active compound loading is validated to ±2% per patch. Batch-to-batch consistency is maintained through closed-environment manufacturing and inline spectroscopic verification at each critical process step.
Controlled Release Kinetics
Release profile is determined by crystal habit, particle size distribution, and polymer dissolution rate — not by a membrane. This eliminates dose-dumping risk and allows the release curve to be tuned at the formulation stage.
Stability & Shelf Life
The anhydrous microcrystal matrix is inherently stable. Accelerated stability studies support a 24-month shelf life at 25 °C / 60% RH in the primary foil sachet, without refrigeration.
Platform Extensibility
The microcrystal platform is compound-agnostic. Formulation parameters are adjusted per active to accommodate solubility, molecular weight, and target release window — enabling rapid pipeline expansion.
Structural anatomy
Patch cross-section
See the platform in action
Follow the four-stage delivery sequence from patch application to systemic uptake.